Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation for Refractory Hepatic Encephalopathy After TIPS
NCT07683936Phase 1Recruiting
- Sponsor
- Air Force Medical University
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Fecal Microbiota Transplantation Capsule in hepatic encephalopathy (HE) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Incidence and severity of treatment-related adverse events and serious adverse events at 6 months. Started Jun 2026; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT07683936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683936.